首页> 外文期刊>Asian Journal of Medical Sciences >The anti-diabetic activities of the methanol leaf extract of Phyllanthus amarus in some laboratory animals
【24h】

The anti-diabetic activities of the methanol leaf extract of Phyllanthus amarus in some laboratory animals

机译:余甘子甲醇叶提取物对某些实验动物的抗糖尿病作用

获取原文
           

摘要

Background: Phyllanthus amarus is used in Nigeria and other parts of the world as a medicinal plant. Aim and objective: The plant is being evaluated for antidiabetic potential because diabetes mellitus has assumed a worldwide dimension and plant with safe potential are being deployed as they are available all year round and are cheap for use by the rural populace. Materials and Methods: The antidiabetic effect of the methanol extract (ME) of Phyllanthus amarus was evaluated in rats. Standard phytochemical methods were used to test for the presence of phytoactive compounds in the plant. Acute toxicity was carried out in mice to determine safe doses for this plant extract. The anti-diabetic activities of the ME of the plant were assessed using some standard tests as well as histological changes in liver, kidney and pancreas. Diabetes mellitus was induced in rats using alloxan while glibenclamide at 0.2mg/kg was the reference drug used in this study. Results: The ME at 200 and 400mg/kg body weight caused a significant reduction of fasting blood glucose, significant change in the oral glucose tolerance test, marked effect in the hypoglycaemic activity test and pronounced reduction on the glucose level of diabetic rats. Histopathologically, there was no visible lesion seen in the liver, kidney and pancreas of extract-treated and glibenclamide-treated groups. Conclusion: This study may have validated the traditional basis for the use of Phyllanthus amarus as an antidiabetic agent. At the doses used, ME also appeared safer than glibenclamide even though the latter is more potent. DOI: http://dx.doi.org/10.3126/ajms.v4i3.6992 Asian Journal of Medical Sciences 4(2013) 23-34
机译:背景:紫花楠在尼日利亚和世界其他地区被用作药用植物。目的和目标:正在评估该植物的抗糖尿病潜力,因为糖尿病已假定具有世界范围的规模,并且具有安全潜力的植物正在部署,因为它们一年四季都可用,并且农村居民廉价使用。材料与方法:评价了紫竹甲醇提取物(ME)的抗糖尿病作用。使用标准植物化学方法测试植物中植物活性化合物的存在。在小鼠中进行了急性毒性以确定该植物提取物的安全剂量。使用一些标准测试以及肝脏,肾脏和胰腺的组织学变化评估了植物ME的抗糖尿病活性。使用四氧嘧啶在大鼠中诱发糖尿病,而本研究中使用的0.2mg / kg格列本脲为参考药物。结果:200和400mg / kg体重的ME导致空腹血糖显着降低,口服葡萄糖耐量试验发生显着变化,降血糖活性试验显着效果以及对糖尿病大鼠葡萄糖水平的显着降低。在组织病理学上,提取物治疗组和格列本脲治疗组的肝,肾和胰腺均未见可见病变。结论:本研究可能已经验证了紫茉莉作为抗糖尿病药的传统基础。在使用的剂量下,ME似乎比格列本脲更安全,尽管后者更有效。 DOI:http://dx.doi.org/10.3126/ajms.v4i3.6992亚洲医学杂志4(2013)23-34

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号